Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03797469 · ClinicalTrials.gov registry record · NA

Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin)

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT03797469: Completed NA study, sponsored by Columbia University.

NCT03797469 is a NA study that has completed, run by Columbia University. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03797469, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

This study seeks to test whether these over-the-counter nutritional supplements have an impact on patients' performance during visual field testing.

Primary Outcome

Changes in 24-2 visual field results based upon point-wise and global metrics before and after intervention, and between treatment and placebo groups will be compared.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Vitamin B3
  • DIETARY_SUPPLEMENT Pyruvate

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2019-04-15
Est. Completion 2020-12-31
Phase NA
Columbia University

958 total trials

What the finished NCT03797469 record still lists

NCT03797469 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT03797469 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03797469 about?

NCT03797469 is a clinical study titled "Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin)". This study seeks to test whether these over-the-counter nutritional supplements have an impact on patients' performance during visual field testing.

What is the current status of trial NCT03797469?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2019-04-15. Estimated completion is 2020-12-31.

What interventions are being tested in trial NCT03797469?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin B3 (DIETARY_SUPPLEMENT), Pyruvate (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03797469?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03797469's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03797469, the US trial registry maintained by the National Library of Medicine. NCT03797469 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.